In 1994, Jintan Depei Research Institute came into being. After more than 20 years of struggle and innovation, the company officially changed its name to Jiangsu Jingye Pharmaceutical Co., Ltd. on May 16, 2016, and obtained the Drug Manufacturing License for Loratadine, Crotamiton, Amitriptyline Hydrochloride and other drugs.

Jingye Pharmaceutical is located in Xuebu Industrial Park, Jintan District, Changzhou City, Jiangsu Province, with convenient water, land and air transportation. Since its establishment, the company has been conscientious and innovative, and has developed into a high-tech enterprise in Jiangsu Province integrating science, industry and trade.

Jingye Pharmaceutical adheres to the principle of strengthening enterprises with talents and continuously recruiting talents. It has established a professional team with independent research and development ability and analysis and testing ability. It has also established longterm and stable cooperative relations with Beijing Zhongguancun Life Science Park, Shanghai Institute of Organic Chemistry of Chinese Academy of Sciences, China Pharmaceutical University, Nanjing University and other units to vigorously promote the industrialization process of scientific and technological achievements.

Every product developed by Jingye Pharmaceutical is a perfect combination of wisdom and technology. The company strictly abide by the GMP standards for production, under the guidance of the enterprise concept of "Jingye pharmaceutical, health protection", during each step of strict quality control, to carefully manufacture every product. The company has the industry leading level in some organic synthesis, such as hydrogenation reaction, high and low temperature reaction, Grignard reaction, chlorination reaction, oxidation reaction.

With decades of consistent persistence and efforts, Jingye Pharmaceutical's products have won high praise from customers at home and abroad. The company's products have been exported to Europe and America and obtained DMF registration and Dun & Bradstreet Certificate.

Up against the wind and running on ceaseless tide. In the future, Jingye will take science and technology as the guide, develop pharmaceutical industrialization and modernization with innovation, and strive to become the "leader of high-quality generic drugs and new drug intermediates".